XML 24 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
$ in Thousands
USD ($)
shares
Share capital
USD ($)
shares
Contributed surplus
USD ($)
Accumulated other comprehensive income (loss)
USD ($)
Retained earnings
USD ($)
Balance (in shares) at Jan. 01, 2023 | shares   179,709,000      
Balance at Jan. 01, 2023 $ 1,882,162 $ 202,329 $ 79,489 $ 9,845 $ 1,590,499
Changes in equity [abstract]          
Share-based compensation 26,804   26,804    
Shares issued under employee share purchase plan (in shares) | shares   54,000      
Shares issued under employee share purchase plan $ 1,622 $ 1,622      
Shares issued pursuant to exercise of stock options (in shares) | shares 463,000 2,054,000      
Shares issued pursuant to exercise of stock options $ 53,617 $ 65,226 (11,609)    
Shares issued or distributed pursuant to vesting of restricted share units (in shares) | shares   856,000      
Shares issued or distributed pursuant to vesting of restricted share units and SARs $ (19,470) $ 17,638 (37,108)    
Shares repurchased for cancellation (note 13(d)) (in shares) | shares (11,830,618) (11,831,000)      
Shares repurchased for cancellation (note 13(d)) $ (370,430) $ (14,786)     (355,644)
Share repurchases for settlement of non-Treasury RSUs (note 13(e)) (in shares) | shares   (856,000)      
Share repurchases for settlement of non-Treasury RSUs (note 13(e)) (26,228) $ (816)     (25,412)
Payout of employee portion of deferred compensation 2,075   2,075    
Dividends declared (131,797)   1,712   (133,509)
Transactions with shareholders of the Company recognized directly in equity (in shares) | shares   (9,723,000)      
Transactions with shareholders of the Company recognized directly in equity (463,807) $ 68,884 (18,126)   (514,565)
Cash flow hedges (note 14(d)) 3,805     3,805  
Actuarial (loss) gain on employee benefit obligations (note 12(a)) 1,717       1,717
Net earnings 533,580       533,580
Comprehensive income $ 539,102     3,805 535,297
Balance (in shares) at Dec. 31, 2023 | shares 169,986,477 169,986,000      
Balance at Dec. 31, 2023 $ 1,957,457 $ 271,213 61,363 13,650 1,611,231
Changes in equity [abstract]          
Share-based compensation 64,376   64,376    
Shares issued under employee share purchase plan (in shares) | shares   43,000      
Shares issued under employee share purchase plan 1,661 $ 1,661      
Shares issued pursuant to exercise of stock options (in shares) | shares   184,000      
Shares issued pursuant to exercise of stock options 5,357 $ 6,304 (947)    
Shares issued or distributed pursuant to vesting of restricted share units (in shares) | shares   658,000      
Shares issued or distributed pursuant to vesting of restricted share units and SARs $ (19,202) $ 20,237 (39,439)    
Shares repurchased for cancellation (note 13(d)) (in shares) | shares (17,735,095) (17,735,000)      
Shares repurchased for cancellation (note 13(d)) $ (761,499) $ (29,670)     (731,829)
Share repurchases for settlement of non-Treasury RSUs (note 13(e)) (in shares) | shares   (725,000)      
Share repurchases for settlement of non-Treasury RSUs (note 13(e)) (27,693) $ (1,188)     (26,505)
Change from equity-settled to cash-settled arising from change in settlement (15,396)   (15,396)    
Payout of employee portion of deferred compensation (1,312)   (1,312)    
Dividends declared (133,469)   1,275   (134,744)
Transactions with shareholders of the Company recognized directly in equity (in shares) | shares   (17,575,000)      
Transactions with shareholders of the Company recognized directly in equity (887,177) $ (2,656) 8,557   (893,078)
Cash flow hedges (note 14(d)) (13,677)     (13,677)  
Actuarial (loss) gain on employee benefit obligations (note 12(a)) (817)       (817)
Net earnings 400,865       400,865
Comprehensive income $ 386,371     (13,677) 400,048
Balance (in shares) at Dec. 29, 2024 | shares 152,410,994 152,411,000      
Balance at Dec. 29, 2024 $ 1,456,651 $ 268,557 $ 69,920 $ (27) $ 1,118,201